Altria Group 10-Q 2026-09-30
MO · CIK 764180 · Form 10-Q · Period ended September 30, 2026 · Filed October 29, 2026
Revenue rose 1.0% to $6.13 billion. Operating margin was 54.0%, against 53.2% a year earlier. Net income was $2.52 billion.
8 sections, 341K characters. Original on sec.gov · ·
| Measure | Quarter ended Sep 30, 2026 | Quarter ended Sep 30, 2025 | Change |
|---|---|---|---|
| Revenue | $6.13B | $6.07B | +1.0% |
| Operating income | $3.31B | $3.23B | +2.6% |
| Net income | $2.52B | $2.38B | +6.0% |
| Diluted EPS | $1.51 | $1.41 | +7.1% |
| Cash and equivalents | $2.70B | n/a | n/a |
| Operating margin* | 54.0% | 53.2% | +0.8 pts |
From the XBRL facts tagged to this filing; both columns are as reported in this filing. * Computed by filings.tools: free cash flow is operating cash flow less capital spending; operating margin is operating income over revenue.
Cover and table of contents
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-Q
(Mark One)
| ☒ | QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
For the quarterly period ended September 30, 2026
or
| ☐ | TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
For the transition period from to
Commission File Number 1-08940
Altria Group, Inc.
(Exact name of registrant as specified in its charter)
| Virginia | 13-3260245 | |||||||||||||
| (State or other jurisdiction of incorporation or organization) | (I.R.S. Employer Identification No.) | |||||||||||||
| 6601 West Broad Street | Richmond | Virginia | 23230 | |||||||||||
| (Address of principal executive offices) | (Zip Code) |
804-274-2200
(Registrant’s telephone number, including area code)
Not Applicable
(Former name, former address and former fiscal year, if changed since last report)
Securities registered pursuant to Section 12(b) of the Act:
| Title of each class | Trading Symbols | Name of each exchange on which registered | ||||||
| Common Stock, $0.33 1/3 par value | MO | New York Stock Exchange | ||||||
| 2.200% Notes due 2027 | MO27 | New York Stock Exchange | ||||||
| 3.125% Notes due 2031 | MO31 | New York Stock Exchange |
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes þ No ¨
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes þ No ¨
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
| Large accelerated filer | þ | Accelerated filer | ☐ | |||||||||||||||||
| Non-accelerated filer | ☐ | Smaller reporting company | ☐ | |||||||||||||||||
| Emerging growth company | ☐ |
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No þ
At October 21, 2026, there were 1,663,436,915 shares outstanding of the registrant’s common stock, par value $0.33 1/3 per share.
ALTRIA GROUP, INC.
TABLE OF CONTENTS
PART I - FINANCIAL INFORMATION
Item 1. Financial Statements
Altria Group, Inc. and Subsidiaries
Condensed Consolidated Balance Sheets
(in millions of dollars)
(Unaudited)
| September 30, 2026 | December 31, 2025 | |||||||||||||
| Assets | ||||||||||||||
| Cash and cash equivalents | $ | 2,697 | $ | 4,474 | ||||||||||
| Receivables | 342 | 263 | ||||||||||||
| Inventories: | ||||||||||||||
| Leaf tobacco | 400 | 531 | ||||||||||||
| Other raw materials | 288 | 245 | ||||||||||||
| Work in process | 17 | 13 | ||||||||||||
| Finished product | 379 | 281 | ||||||||||||
| 1,084 | 1,070 | |||||||||||||
| Other current assets | 675 | 125 | ||||||||||||
| Total current assets | 4,798 | 5,932 | ||||||||||||
| Property, plant and equipment, at cost | 4,588 | 4,672 | ||||||||||||
| Less accumulated depreciation | 2,919 | 2,962 | ||||||||||||
| 1,669 | 1,710 | |||||||||||||
| Goodwill | 5,787 | 5,787 | ||||||||||||
| Other intangible assets, net | 11,829 | 11,876 | ||||||||||||
| Investments in equity securities | 9,326 | 8,617 | ||||||||||||
| Other assets | 1,069 | 1,095 | ||||||||||||
| Total Assets | $ | 34,478 | $ | 35,017 |
See notes to condensed consolidated financial statements.
Altria Group, Inc. and Subsidiaries
Condensed Consolidated Balance Sheets (Continued)
(in millions of dollars, except share and per share data)
(Unaudited)
________________________________________________
| September 30, 2026 | December 31, 2025 | |||||||||||||
| Liabilities | ||||||||||||||
| Current portion of long-term debt | $ | 1,175 | $ | 1,569 | ||||||||||
| Accounts payable | 778 | 750 | ||||||||||||
| Accrued liabilities: | ||||||||||||||
| Marketing | 980 | 928 | ||||||||||||
| Settlement charges | 1,942 | 2,178 | ||||||||||||
| Other | 1,558 | 1,947 | ||||||||||||
| Dividends payable | 1,857 | 1,782 | ||||||||||||
| Total current liabilities | 8,290 | 9,154 | ||||||||||||
| Long-term debt | 22,886 | 24,140 | ||||||||||||
| Deferred income taxes | 3,577 | 3,370 | ||||||||||||
| Accrued pension costs | 116 | 122 | ||||||||||||
| Accrued postretirement health care costs | 942 | 939 | ||||||||||||
| Other liabilities | 840 | 744 | ||||||||||||
| Total liabilities | 36,651 | 38,469 | ||||||||||||
| Contingencies (Note 12) | ||||||||||||||
| Stockholders’ Equity (Deficit) | ||||||||||||||
| Common stock, par value $0.33 1/3 per share (2,805,961,317 shares issued) | 935 | 935 | ||||||||||||
| Additional paid-in capital | 5,916 | 5,921 | ||||||||||||
| Earnings reinvested in the business | 37,046 | 35,452 | ||||||||||||
| Accumulated other comprehensive losses | (2,213) | (2,627) | ||||||||||||
| Cost of repurchased stock (1,142,053,089 shares at September 30, 2026 and 1,131,643,020 shares at December 31, 2025) | (43,909) | (43,183) | ||||||||||||
| Total stockholders’ equity (deficit) attributable to Altria | (2,225) | (3,502) | ||||||||||||
| Noncontrolling interest | 52 | 50 | ||||||||||||
| Total stockholders’ equity (deficit) | (2,173) | (3,452) | ||||||||||||
| Total Liabilities and Stockholders’ Equity (Deficit) | $ | 34,478 | $ | 35,017 |
See notes to condensed consolidated financial statements.
Altria Group, Inc. and Subsidiaries
Condensed Consolidated Statements of Earnings
(in millions of dollars, except per share data)
(Unaudited)
_____________________________________
| For the Nine Months Ended September 30, | For the Three Months Ended September 30, | |||||||||||||||||||||||||
| 2026 | 2025 | 2026 | 2025 | |||||||||||||||||||||||
| Net revenues | $ | 17,671 | $ | 17,433 | $ | 6,132 | $ | 6,072 | ||||||||||||||||||
| Cost of sales | 4,288 | 4,149 | 1,500 | 1,439 | ||||||||||||||||||||||
| Excise taxes on products | 2,116 | 2,373 | 691 | 821 | ||||||||||||||||||||||
| Gross profit | 11,267 | 10,911 | 3,941 | 3,812 | ||||||||||||||||||||||
| Marketing, administration and research costs | 1,838 | 1,787 | 625 | 580 | ||||||||||||||||||||||
| Exit costs | 24 | 3 | 3 | 2 | ||||||||||||||||||||||
| Impairment of goodwill | — | 873 | — | — | ||||||||||||||||||||||
| Operating income | 9,405 | 8,248 | 3,313 | 3,230 | ||||||||||||||||||||||
| Interest and other debt expense, net | 823 | 815 | 270 | 278 | ||||||||||||||||||||||
| Net periodic benefit income, excluding service cost | (9) | (45) | (5) | (16) | ||||||||||||||||||||||
| (Income) losses from investments in equity securities | (487) | (398) | (242) | (107) | ||||||||||||||||||||||
| Earnings before income taxes | 9,078 | 7,876 | 3,290 | 3,075 | ||||||||||||||||||||||
| Provision for income taxes | 2,083 | 2,046 | 776 | 700 | ||||||||||||||||||||||
| Net earnings | 6,995 | 5,830 | 2,514 | 2,375 | ||||||||||||||||||||||
| Net losses attributable to noncontrolling interest | 4 | — | 4 | — | ||||||||||||||||||||||
| Net earnings attributable to Altria | $ | 6,999 | $ | 5,830 | $ | **2 |
Showing the first 8K of 163K characters. Open the full section
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations
The following Management’s Discussion and Analysis of Financial Condition and Results of Operations (“MD&A”) should be read in conjunction with the other sections in this Quarterly Report on Form 10-Q (“Form 10-Q”), including our condensed consolidated financial statements and related notes contained in Item 1. Financial Statements of this Form 10-Q (“Item 1”). All references to “Notes” in this MD&A are to Notes to our condensed consolidated financial statements in Item 1. When used in this Form 10-Q, the terms “Altria,” “we,” “us” and “our” refer to either (i) Altria Group, Inc. and its consolidated subsidiaries or (ii) Altria Group, Inc. only and not its consolidated subsidiaries, as appropriate in the context.
In this MD&A section, we refer to the following “adjusted” financial measures: adjusted operating companies income (loss) (“OCI”); adjusted OCI margins; adjusted net earnings attributable to Altria; adjusted diluted earnings per share (“EPS”); and adjusted effective tax rates. We also refer to the ratio of debt-to-Consolidated EBITDA (earnings before interest, taxes, depreciation and amortization, as defined in our credit agreement, which includes certain adjustments). These financial measures are not required by, or calculated in accordance with, United States generally accepted accounting principles (“GAAP”) and may not be calculated the same as similarly titled measures used by other companies. These financial measures should thus be considered as supplemental in nature and not considered in isolation or as a substitute for the related financial information prepared in accordance with GAAP. For a further description of these non-GAAP financial measures, see the Non-GAAP Financial Measures section below.
Executive Summary
Our Business
We are a leader in nicotine with a growing portfolio of products for adult nicotine consumers age 21+. Today, we are focused on elevating everyday moments by offering adult nicotine consumers a range of product choices and the information they need to make informed decisions.
We are Moving Beyond Smoking® by responsibly transitioning adult smokers to a smoke-free future, competing vigorously for existing smoke-free adult nicotine consumers and exploring new growth opportunities - beyond the United States and beyond nicotine (“Vision”). We previously established our 2028 Enterprise Goals (“2028 Goals”) to provide our investors with specific metrics to measure our progress as we execute on our Vision. For further discussion of our 2028 Goals, see our Annual Report on Form 10-K for the year ended December 31, 2025 (“2025 Form 10-K”).
Our American roots stretch back more than 200 years, and our operating companies’ brands have served adult nicotine consumers for generations. The brand portfolios of our operating companies include Marlboro®, Black & Mild®, Copenhagen®, Skoal®, on!® and NJOY®. Our wholly owned subsidiaries include Philip Morris USA Inc. (“PM USA”), John Middleton Co. (“Middleton”), U.S. Smokeless Tobacco Company LLC (“USSTC”), Helix Innovations LLC (“Helix”) and NJOY, LLC (“NJOY”).
We also have a majority-owned joint venture, Horizon Innovations LLC, for the U.S. marketing and commercialization of heated tobacco stick products. Our investments in equity securities include Anheuser-Busch InBev SA/NV (“ABI”), the world’s largest brewer, and Cronos Group Inc. (“Cronos”), a leading Canadian cannabinoid company.
For additional information, see Note 1. Background and Basis of Presentation.
Trends and Developments
In this section of the MD&A, we discuss certain factors that have impacted our businesses as of the date of this Form 10-Q. In addition, we are aware of and address certain trends and developments that could, individually or in the aggregate, have a material impact on our businesses, including the value of our investments in equity securities, in the future. In this section, we focus on the discretionary income pressures on adult nicotine consumers, evolving consumer preferences, illicit flavored disposable e-vapor products and supply chain disruptions. Other trends and developments are discussed elsewhere in this MD&A.
Through the third quarter of 2026, U.S. adult nicotine consumers continued to face inflationary pressures on discretionary income, particularly among price sensitive consumers. Geopolitical uncertainty and developments in the Middle East have continued to contribute to energy price volatility, with gas prices averaging $4.36 per gallon in September. Elevated energy costs contributed to September inflation of 3.7%, remaining above the Federal Reserve’s 2% target.
Overall discretionary income pressures on adult nicotine consumers have resulted in increased discount brand share and contributed to evolving adult nicotine consumer preferences, each of which has negatively impacted the sales volumes of certain of our operating companies’ premium brands. For the third quarter of 2026, the discount retail share of the cigarette category reached 34.1%, an increase of 2.0 share points versus the third quarter of 2025 and 0.3 share points sequentially. When adjusted for trade inventory movements, our smokeable products segment domestic cigarette shipment volume declined by an estimated 4% in the third quarter of 2026 versus the third quarter of 2025. When adjusted for trade inventory movements, total estimated domestic cigarette industry volume declined by 5% in the third quarter of 2026 versus the third quarter of 2025. The U.S. nicotine pouch category continued to grow throughout the third quarter of 2026 to 61.2% of the U.S. oral tobacco category, an increase of 5.8 share points versus the third quarter of 2025 and 1.3 share points sequentially. As innovative smoke-free products evolve to better address the preferences of adult nicotine consumers, these consumers continue to transition from cigarettes and moist smokeless tobacco (“MST”) products to innovative smoke-free products, which has reduced the sales volumes of our operating companies’ cigarette and MST products.
Various states and the federal government have taken regulatory and enforcement actions against manufacturers, distributors and retailers of illicit flavored disposable e-vapor products. For example, the U.S. Food and Drug Administration (“FDA”) and U.S. Customs and Border Protection have made it more difficult to import properly declared illicit e-vapor products, seized unauthorized e-vapor products and issued warning letters to importers. Despite these enforcement measures, insufficient actions against manufacturers, distributors and retailers of nicotine products requiring FDA review for which no premarket tobacco product applications (“PMTA”) have been submitted have allowed such products to continue to proliferate in the market. We expect that effective enforcement against illicit products will occur gradually and continue to monitor the overall dynamics and competitive threats to our brands across multiple nicotine categories.
We are monitoring volatility in domestic and global economies and disruptions in the supply and distribution chains. This volatility and disruption are the result of several factors, including macroeconomic conditions, raw materials availability and geopolitical events. We continue to assess the impact of volatility on price, availability or quality of tobacco, other raw materials or component parts, and work to mitigate the potential negative impacts of macroeconomic and geopolitical dynamics on our businesses through, among other actions, proactive engagement with current and potential suppliers and distributors and the development of alternative sourcing strategies.
See Operating Results by Business Segment - Business Environment for additional information on the trends and developments discussed above.
The trends and developments above have not had a material adverse impact on our results of operations, cash flows or financial position
Showing the first 8K of 161K characters. Open the full section
Item 3. Quantitative and Qualitative Disclosures About Market Risk
Interest Rate Risk
The fair value of our long-term debt, all of which is fixed-rate debt, is subject to fluctuations resulting primarily from changes in market interest rates. The fair value of our long-term debt and the change in fair value based on a 1% increase or decrease in market interest rates were as follows:
| (in billions) | September 30, 2026 | December 31, 2025 | ||||||||||||
| Fair value | $ | 21.0 | $ | 24.3 | ||||||||||
| Decrease in fair value from a 1% increase in market interest rates | 1.5 | 1.8 | ||||||||||||
| Increase in fair value from a 1% decrease in market interest rates | 1.7 | 2.1 |
Item 4. Controls and Procedures
We carried out an evaluation, with the participation of our management, including our Chief Executive Officer and Chief Financial Officer, of the effectiveness of our disclosure controls and procedures (as defined in Rule 13a-15(e)) under the Securities Exchange Act of 1934, as amended, as of the end of the period covered by this Form 10-Q. Based upon that evaluation, our Chief Executive Officer and Chief Financial Officer concluded that our disclosure controls and procedures are effective.
There have been no changes in our internal control over financial reporting during the most recent fiscal quarter that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.
Part II – OTHER INFORMATION
Item 1. Legal Proceedings
See Note 12 for a discussion of legal proceedings pending against us. See also Exhibits 99.1 and 99.2 to this Form 10-Q.
Item 1A. Risk Factors
Information regarding Risk Factors appears in Part I, Item 1A. Risk Factors of our 2025 Form 10-K. There have been no material changes to the risk factors previously disclosed in our 2025 Form 10-K.
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds
In January 2025, our Board authorized a $1.0 billion share repurchase program. In October 2025, the Board authorized a $1.0 billion expansion of this program to $2.0 billion, which was set to expire on December 31, 2026 (as expanded, “January 2025 share repurchase program”). In October 2026, our Board authorized a $1.0 billion expansion of this program, which now expires on December 31, 2027. Share repurchases depend on marketplace conditions and other factors, and the program remains subject to the discretion of our Board.
Our share repurchase activity for each of the three months in the period ended September 30, 2026, was as follows:
| Period | Total Number of Shares Purchased (1) | Average Price Paid Per Share | Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs | Approximate Dollar Value of Shares that May Yet be Purchased Under the Plans or Programs | ||||||||||||||||||||||
| July 1-31, 2026 | — | $ | — | — | $ | 664,941,491 | ||||||||||||||||||||
| August 1-31, 2026 | 887,264 | $ | 64.83 | 886,300 | $ | 607,488,077 | ||||||||||||||||||||
| September 1-30, 2026 | 4,951,632 | $ | 69.18 | 4,951,632 | $ | 264,941,547 | ||||||||||||||||||||
| 5,838,896 | $ | 68.52 | 5,837,932 |
(1) The total number of shares purchased includes (a) shares purchased under the January 2025 share repurchase program and (b) shares withheld by Altria in an amount equal to the statutory withholding taxes for vested stock-based awards previously granted to eligible employees (which totaled 964 in August).
Item 5. Other Information
During the quarter ended September 30, 2026, none of our directors or officers adopted, modified or terminated any “Rule 10b5-1 trading arrangement” or “non-Rule 10b5-1 trading arrangement,” as each term is defined in Item 408(a) of Regulation S-K.
Item 6. Exhibits
| 22 | Guarantor Subsidiary of the Registrant. | |||||||
| 31.1 | Certification of Chief Executive Officer pursuant to Rule 13a-14(a)/15d-14(a) of the Securities Exchange Act of 1934, as amended, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. | |||||||
| 31.2 | Certification of Chief Financial Officer pursuant to Rule 13a-14(a)/15d-14(a) of the Securities Exchange Act of 1934, as amended, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. | |||||||
| 32.1 | Certification of Chief Executive Officer pursuant to 18 U.S.C. 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002. | |||||||
| 32.2 | Certification of Chief Financial Officer pursuant to 18 U.S.C. 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002. | |||||||
| 99.1 | Certain Litigation Matters. | |||||||
| 99.2 | Trial Schedule for Certain Cases. | |||||||
| 101 | The following financial statements from our Quarterly Report on Form 10-Q for the quarter ended September 30, 2026, formatted in Inline XBRL: (i) Condensed Consolidated Statements of Cash Flows, (ii) Condensed Consolidated Statements of Earnings, (iii) Condensed Consolidated Statements of Comprehensive Earnings, (iv) Condensed Consolidated Balance Sheets, (v) Condensed Consolidated Statements of Stockholders’ Equity (Deficit), and (vi) Notes to Condensed Consolidated Financial Statements, tagged as blocks of text and including detailed tags. Inline XBRL Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document. | |||||||
| 104 | Cover Page Interactive Data File (formatted as inline XBRL and contained in Exhibit 101). |
Signature
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
ALTRIA GROUP, INC.
/s/ HEATHER A. NEWMAN
Heather A. Newman
Executive Vice President and
Chief Financial Officer
October 29, 2026